| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.6% | 3.0% |
| Div Cover | 4.8 | 3.8 |
| Op Mrgn | 26.8% | 23.7% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | 7.8 | 8.6 |
| PEG | n/a | n/a |
| Pr/Revenue | 1.5 | 1.5 |
| Pr/Book | 1.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -7.9% | 1.3% |
| PBT | -16.8% | 3.0% |
| EPS | -28.6% | -9.0% |
| DPS | 31.6% | 14.8% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 18.22 | (3.21) | 0.23p | 27.2 | n/a | -28% | n/a | 0.0% |
| 31-Dec-08 | 21.76 | 2.42 | 1.17p | 2.2 | 0.0 | +409% | n/a | 0.0% |
| 31-Dec-09 | 31.24 | 5.74 | 3.55p | 7.5 | 0.0 | +203% | 0.30p | 1.1% |
| 31-Dec-10 | 49.88 | 12.87 | 5.07p | 6.1 | 0.1 | +43% | 0.57p | 1.8% |
| 31-Dec-11 | 45.96 | 10.71 | 3.62p | 8.5 | n/a | -29% | 0.75p | 2.4% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 46.57 | 11.03 | 3.29p | 8.6 | n/a | -9% | 0.86p | 3.0% |
| 31-Dec-13 | 48.55 | 12.17 | 3.67p | 7.7 | 0.7 | +11% | 0.92p | 3.2% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| AGM Statement | 23-May-2012 | 07:00 | RNS |
| Notification of Major Interest in Shares | 14-May-2012 | 11:09 | RNS |
| Notice of AGM | 10-Apr-2012 | 12:01 | RNS |
| Alliance Pharma shares fall sharply, in part due... | 16-Jan-2012 | ShareCast |
| Alliance Pharma hikes dividend | 07-Sep-2011 | ShareCast |
| Alliance Pharma cuts sales guidance | 26-May-2011 | ShareCast |
| Drug sales lead the way for Boots as revenues ri... | 31-Oct-2008 | The Scotsman |
| Look ahead | 13-Sep-2006 | Times |
| Look ahead | 12-May-2006 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 28.38p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 31.75p |
| 52 Week Low | 26.25p |
| Volume | 579,735 |
| Shares Issued | 240.11m |
| Market Cap | £68.13m |
| Beta | 0.19 |
| RiskGrade | 73 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 0 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 13-Jun-12 | 30-Nov-11 |
| Paid | 12-Jul-12 | 13-Jan-12 |
| Amount | 0.50p | 0.25p |
| Time | Volume / Share Price |
| 12:34 | 467,857 @ 28.25p |
| 11:39 | 5,000 @ 28.46p |
| 11:22 | 8,000 @ 28.31p |
| 11:12 | 48,500 @ 28.75p |
| 11:11 | 50,000 @ 28.50p |
| CEO | John Dawson |
| Finance Director | Richard Wright |
You are here: research